Dysmenorrhea in adolescents: Diagnosis and treatment

Pediatric Drugs

Volumn 10, Issue 1, 2008, Pages 1-7

  French, Linda ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

Adolescents; Contraceptives, therapeutic use; Dysmenorrhoea, diagnosis; Dysmenorrhoea, treatment; Gonadotropin releasing hormone agonists, therapeutic use; Levonorgestrel, therapeutic use; Medroxyprogesterone, therapeutic use

Indexed keywords

ACETYLSALICYLIC ACID; ANASTROZOLE; ANGIOGENESIS INHIBITOR; CELECOXIB; DANAZOL; DEPO MEDROXYPROGESTERONE ACETATE; DICLOFENAC; ETHINYLESTRADIOL; FISH OIL; GLYCERYL TRINITRATE; GONADORELIN AGONIST; GOSERELIN; IBUPROFEN; LETROZOLE; LEUPRORELIN; LEVONORGESTREL; MEFENAMIC ACID; NAPROXEN; NIFEDIPINE; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL CONTRACEPTIVE AGENT; PARACETAMOL; PROGESTERONE DERIVATIVE; PROGESTERONE RECEPTOR MODULATOR; PROSTAGLANDIN; TERBUTALINE; THIAMINE; TOCOPHEROL; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASOPRESSIN;

ACNE; ACUPUNCTURE; CHLAMYDIA TRACHOMATIS; CLINICAL TRIAL; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; DYSMENORRHEA; ENDOMETRIOSIS; FATIGUE; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; LAPAROSCOPY; LIFESTYLE MODIFICATION; MANIPULATIVE MEDICINE; MENSTRUAL CYCLE; MONOTHERAPY; NEISSERIA GONORRHOEAE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SCREENING; SENSITIVITY AND SPECIFICITY; SEXUALLY TRANSMITTED DISEASE; SIDE EFFECT; SOCIAL STATUS; SURGICAL TECHNIQUE; TRANSCUTANEOUS NERVE STIMULATION; TRANSVAGINAL ECHOGRAPHY; UTERUS CONTRACTILITY; WEIGHT GAIN;

ADOLESCENT; DRUG THERAPY; DYSMENORRHEA; ENDOMETRIOSIS; FEMALE; HEAT; HUMANS; MAGNETICS; RISK FACTORS; SMOKING;

EID: 37549038230     PISSN: 11745878     EISSN: None     Source Type: Journal    
DOI: 10.2165/00148581-200810010-00001     Document Type: Review

References (65)

1. Davis AR, Westhoff CL. Primary dysmenorrhea in adolescent girls and treatment with oral contraceptives. J Pediatr Adolesc Gynecol 2001 Feb; 14 (1): 3-8
2. Banikarim C, Chacko MR, Kelder SH. Prevalence and impact of dysmenorrhea on Hispanic female adolescents. Arch Pediatr Adolesc Med 2000 Dec; 154 (12): 1226-9
3. Strinic T, Bukovic D, Pavelic L, et al. Anthropological and clinical characteristics in adolescent women with dysmenorrhea. Coll Antropol 2003 Dec; 27 (2): 707-11
4. Klein JR, Litt IF. Epidemiology of adolescent dysmenorrhea. Pediatrics 1981 Nov; 68 (5): 661-4
5. Sundell G, Milsom I, Andersch B. Factors influencing the prevalence and severity of dysmenorrhoea in young women. Br J Obstet Gynaecol 1990 Jul; 97 (7): 588-94
6. Jabbour HN, Sales KJ, Smith OP, et al. Prostaglandin receptors are mediators of vascular function in endometrial pathologies. Mol Cell Endocrinol 2006 Jun 27; 252 (1-2): 191-200
7. Liedman R, Skillern L, James I, et al. Validation of a test model of induced dysmenorrhea. Acta Obstet Gynecol Scand 2006; 85: 451-7
8. Burnett MA, Antao V, Black A, et al. Prevalence of primary dysmenorrhea in Canada. J Obstet Gynaecol Can 2005 Aug; 27 (8): 765-70
9. Teperi J, Rimpela M. Menstrual pain, health, and behaviour in girls. Soc Sci Med 1989; 29 (2): 163-9
10. Andersch B, Milsom I. An epidemiologic study of young women with dysmenorrhea. Am J Obstet Gynecol 1982 Nov 15; 144 (6): 655-60
11. Juang CM, Yen MS, Twu NF, et al. Impact of pregnancy on primary dysmenorrhea. Int J Gynaecol Obstet 2006 Mar; 92 (3): 221-7
12. Harlow SD, Park M. A longitudinal study of risk factors for the occurrence, duration and severity of menstrual cramps in a cohort of college women. Br J Obstet Gynaecol 1996 Nov; 103 (11): 1134-42
13. Parazzini F, Tozzi L, Mezzopane R, et al. Cigarette smoking, alcohol consumption, and risk of primary dysmenorrhea. Epidemiology 1994 Jul; 5 (4): 469-72
14. Rapkin AJ, Tsao JC, Turk N, et al. Relationships among self-rated tanner staging, hormones, and psychosocial factors in healthy female adolescents. J Pediatr Adolesc Gynecol 2006 Jun; 19 (3): 181-7
15. Montero P, Bernis C, Fernandez V, et al. Influence of body mass index and slimming habits on menstrual pain and cycle irregularity. J Biosoc Sci 1996 Jul; 28 (3): 315-23
16. American Society for Reproductive Medicine. Revised American Society for Reproductive Medicine classification of endometriosis: 1996. Fertil Steril 1997; 67 (5): 817-21
17. Proctor M, Farquhar C. The diagnosis and management of dysmenorrhoea. BMJ 2006; 132: 1134-8
18. Farquhar C. Endometriosis. BMJ 2007; 334: 249-53
19. US Preventive Services Task Force, Agency for Healthcare Research and Quality. Screening for gonorrhea: summary of recommendations [online]. Available from URL: http://www.ahrq.gov/clinic/uspstf/uspsgono.htm [Accessed 2007 Nov 21]
20. Moore J, Copley S, Morris J, et al. A systematic review of the accuracy of ultrasound in the diagnosis of endometriosis. Ultrasound Obstet Gynecol 2002 Dec; 20 (6): 630-4
21. Exacoustos C, Zupi E, Carusotti C, et al. Staging of pelvic endometriosis: role of sonographic appearance in determining extension of disease and modulating surgical approach. J Am Assoc Gynecol Laparosc 2003 Aug; 10 (3): 378-82
22. Dessole S, Farina M, Rubattu G, et al. Sonovaginography is a new technique for assessing rectovaginal endometriosis. Fertil Steril 2003 Apr; 79 (4): 1023-7
23. Stratton P, Winkel C, Premkumar A, et al. Diagnostic accuracy of laparoscopy, magnetic resonance imaging, and histopathologic examination for the detection of endometriosis. Fertil Steril 2003 May; 79 (5): 1078-85
24. Practice Committee of the American Society of Reproductive Medicine. Treatment of pelvic pain associated with endometriosis. Fertil Steril 2006 Nov; 86 (5 Suppl.): S18-27
25. Ballweg ML. Impact of endometriosis on women's health: comparative historical data show that the earlier the onset, the more severe the disease. Best Pract Res Clin Obstet Gynaecol 2004 Apr; 18 (2): 201-18
26. Proctor ML, Farquhar CM. Dysmenorrhoea. In: Group BP, editor. Clinical evidence. London: BMJ Publishing Group, 2003: 2058-78
27. Maia Jr H, Maltez A, Studard E, et al. Effect of the menstrual cycle and oral contraceptives on cyclooxygenase-2 expression in the endometrium. Gynecol Endocrinol 2005 Jul; 21 (1): 57-61
28. Davis AR, Westhoff C, O'Connell K, et al. Oral contraceptives for dysmenorrhea in adolescent girls: a randomized trial. Obstet Gynecol 2005 Jul; 106 (1): 97-104
29. Hendrix SL, Alexander NJ. Primary dysmenorrhea treatment with a desogestrel-containing low-dose oral contraceptive. Contraception 2002 Dec; 66 (6): 393-9
30. Milsom I, Sundell G, Andersch B. The influence of different combined oral contraceptives on the prevalence and severity of dysmenorrhea. Contraception 1990 Nov; 42 (5): 497-506
31. Edelman AB, Gallo MF, Jensen JT, et al. Continuous or extended cycle vs. cyclic use of combined oral contraceptives for contraception. Cochrane Database Syst Rev 2005; (3): CD004695
32. Sulak PJ, Kuehl TJ, Ortiz M, et al. Acceptance of altering the standard 21-day/7-day oral contraceptive regimen to delay menses and reduce hormone withdrawal symptoms. Am J Obstet Gynecol 2002 Jun; 186 (6): 1142-9
33. Baldaszti E, Wimmer-Puchinger B, Loschke K. Acceptability of the long-term contraceptive levonorgestrel-releasing intrauterine system (Mirena): a 3-year follow-up study. Contraception 2003 Feb; 67 (2): 87-91
34. Harel Z, Riggs S, Vaz R, et al. Adolescents' experience with the combined estrogen and progestin transdermal contraceptive method Ortho Evra. J Pediatr Adolesc Gynecol 2005 Apr; 18 (2): 85-90
35. Ziaei S, Rajaei L, Faghihzadeh S, et al. Comparative study and evaluation of side effects of low-dose contraceptive pills administered by the oral and vaginal route. Contraception 2002 May; 65 (5): 329-31
36. Audet MC, Moreau M, Koltun WD, et al. Evaluation of contraceptive efficacy and cycle control of a transdermal contraceptive patch vs an oral contraceptive: a randomized controlled trial. JAMA 2001 May 9; 285 (18): 2347-54
37. Facchinetti F, Sgarbi L, Piccinini F, et al. A comparison of glyceryl trinitrate with diclofenac for the treatment of primary dysmenorrhea: an open, randomized, cross-over trial. Gynecol Endocrinol 2002 Feb; 16 (1): 39-43
38. Akerlund M, Andersson KE. Effects of terbutaline on human myometrial activity and endometrial blood flow. Obstet Gynecol 1976 May; 47 (5): 529-35
39. Andersson KE, Ulmsten U. Effects of nifedipine on myometrial activity and lower abdominal pain in women with primary dysmenorrhoea. Br J Obstet Gynaecol 1978 Feb; 85 (2): 142-8
40. Selak V, Farquhar C, Prentice A, et al. Danazol for pelvic pain associated with endometriosis. Cochrane Database Syst Rev 2001; (4): CD000068
41. Meresman GF, Bilotas M, Abello V, et al. Effects of aromatase inhibitors on proliferation and apoptosis in eutopic endometrial cell cultures from patients with endometriosis. Fertil Steril 2005 Aug; 84 (2): 459-63
42. Hefler LA, Grimm C, van Trotsenburg M, et al. Role of the vaginally administered aromatase inhibitor anastrozole in women with rectovaginal endometriosis: a pilot study. Fertil Steril 2005 Oct; 84 (4): 1033-6
43. Amsterdam LL, Gentry W, Jobanputra S, et al. Anastrazole and oral contraceptives: a novel treatment for endometriosis. Fertil Steril 2005 Aug; 84 (2): 300-4
44. Ailawadi RK, Jobanputra S, Kataria M, et al. Treatment of endometriosis and chronic pelvic pain with letrozole and norethindrone acetate: a pilot study. Fertil Steril 2004 Feb; 81 (2): 290-6
45. Soysal S, Soysal ME, Ozer S, et al. The effects of post-surgical administration of goserelin plus anastrozole compared to goserelin alone in patients with severe endometriosis: a prospective randomized trial. Hum Reprod 2004 Jan; 19 (1): 160-7
46. Olive DL, Lindheim SR, Pritts EA. New medical treatments for endometriosis. Best Pract Res Clin Obstet Gynaecol 2004 Apr; 18 (2): 319-28
47. Ferrero S, Abbamonte LH, Anserini P, et al. Future perspectives in the medical treatment of endometriosis. Obstet Gynecol Surv 2005 Dec; 60 (12): 817-26
48. Barnard ND, Scialli AR, Hurlock D, et al. Diet and sex-hormone binding globulin, dysmenorrhea, and premenstrual symptoms. Obstet Gynecol 2000 Feb; 95 (2): 245-50
49. Nagata C, Hirokawa K, Shimizu N, et al. Associations of menstrual pain with intakes of soy, fat and dietary fiber in Japanese women. Eur J Clin Nutr 2005 Jan; 59 (1): 88-92
50. Gokhale LB. Curative treatment of primary (spasmodic) dysmenorrhoea. Indian J Med Res 1996 Apr; 103: 227-31
51. Vitamin E for dysmenorrhea. Bandolier, 2005 [online]. Available from URL: http://www.jr2.ox.ac.uk/bandolier/band136/b136-6.html [Accessed 2007 Nov 14]
52. Ziaei S, Zakeri M, Kazemnejad A. A randomised controlled trial of vitamin E in the treatment of primary dysmenorrhoea. BJOG 2005 Apr; 112 (4): 466-9
53. Vivekananthan DP, Penn MS, Sapp SK, et al. Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials. Lancet 2003 Jun 14; 361 (9374): 2017-23
54. Harel Z, Biro FM, Kottenhahn RK, et al. Supplementation with omega-3 polyunsaturated fatty acids in the management of dysmenorrhea in adolescents. Am J Obstet Gynecol 1996 Apr; 174 (4): 1335-8
55. Deutch B. Menstrual pain in Danish women correlated with low n-3 polyunsaturated fatty acid intake. Eur J Clin Nutr 1995 Jul; 49 (7): 508-16
56. Eccles NK. A randomized, double-blinded, placebo-controlled pilot study to investigate the effectiveness of a static magnet to relieve dysmenorrhea. J Altern Complement Med 2005 Aug; 11 (4): 681-7
57. Helms JM. Acupuncture for the management of primary dysmenorrhea. Obstet Gynecol 1987 Jan; 69 (1): 51-6
58. Pouresmail Z, Ibrahimzadeh R. Effects of acupressure and ibuprofen on the severity of primary dysmenorrhea. J Tradit Chin Med 2002 Sep; 22 (3): 205-10
59. Taylor D, Miaskowski C, Kohn J. A randomized clinical trial of the effectiveness of an acupressure device (relief brief) for managing symptoms of dysmenorrhea. J Altern Complement Med 2002 Jun; 8 (3): 357-70
60. Dawood MY, Ramos J. Transcutaneous electrical nerve stimulation (TENS) for the treatment of primary dysmenorrhea: a randomized crossover comparison with placebo TENS and ibuprofen. Obstet Gynecol 1990 Apr; 75 (4): 656-60
61. Proctor ML, Smith CA, Farquhar CM, et al. Transcutaneous electrical nerve stimulation and acupuncture for primary dysmenorrhoea. Cochrane Database Syst Rev 2002; (1): CD002123
62. Akin MD, Weingand KW, Hengehold DA, et al. Continuous low-level topical heat in the treatment of dysmenorrhea. Obstet Gynecol 2001 Mar; 97 (3): 343-9
63. Hondras MA, Long CR, Brennan PC. Spinal manipulative therapy versus a low force mimic maneuver for women with primary dysmenorrhea: a randomized, observer-blinded, clinical trial. Pain 1999 May; 81 (1-2): 105-14
64. Proctor ML, Hing W, Johnson TC, et al. Spinal manipulation for primary and secondary dysmenorrhoea. Cochrane Database Syst Rev 2001; (4): CD002119
65. Wilson ML, Farquhar CM, Sinclair OJ, et al. Surgical interruption of pelvic nerve pathways for primary and secondary dysmenorrhoea. Cochrane Database Syst Rev 2000; (2): CD001896